| Previous Close | 49.48 |
|---|---|
| Volume | 150,882 |
| Day's Range | 48.97 - 50.00 |
| 52-Week Range | 43.03 - 56.92 |
| Year-to-Date Return | -6.64% |
|---|---|
| 1-Year Return | -5.21% |
| 3-Year Annualized Return | 0.13% |
| 5-Year Annualized Return | NA% |
| Expense Ratio | 0.35 |
|---|---|
| Net Assets | $ 371 mil |
| Alpha | 0.21 |
| R-Squared | 0.28 |
| Dividend (Yield) | $0.15 (0.34%) |
| Avg. Market Cap | $ 8,350 mil |
| Beta | 0.64 |
| Price/Earnings | 29.31 |
| Ex-Dividend Date | 3/20/2009 |
| Turnover | 78.00 |
| Standard Deviation | 7.01 |
| Price/Book | 4.91 |
| Management Company | State Street Bank & Trust CO/IFTC |
| Administrator | SSGA Funds Management Inc |
| Company of Name | % of Total | # of Shares Held |
|---|---|---|
| 1. Regeneron Pharmaceuticals Inc | 5.44% | 1,113,523 |
| 2. ONYX Pharmcetcl | 4.80% | 697,158 |
| 3. Celgene Corp | 4.72% | 421,364 |
| 4. Cubist Pharmaceuticals Inc | 4.68% | 1,052,985 |
| 5. Vertex Pharma | 4.64% | 577,774 |
| 6. Amgen | 4.64% | 361,487 |
| 7. Alexion Pharm | 4.49% | 463,671 |
| 8. OSI Pharmaceuticals Inc | 4.46% | 620,879 |
| 9. Biomarin Pharmaceutical Inc | 4.36% | 1,232,572 |
| 10. Theravance | 4.35% | 1,301,217 |
| % of Total Holdings | 46.58% |